Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Advisors Capital Management LLC Increases Holdings in Abbott Laboratories $ABT
03:12am, Friday, 14'th Nov 2025
Advisors Capital Management LLC raised its position in shares of Abbott Laboratories (NYSE: ABT) by 1.4% in the second quarter, according to the company in its most recent filing with the SEC. The ins
Goldman Sachs Says US Stocks Could Lag for 10 Years: 5 Strong Buy Value Dividend Ideas
01:46pm, Thursday, 13'th Nov 2025
Goldman Sachs has projected that U.S. stocks will deliver lackluster returns over the next decade primarily due to two key factors: extreme market concentration and elevated valuations.
Invesco Diversified Dividend Fund Q3 2025 Portfolio Positioning
03:58am, Wednesday, 12'th Nov 2025
Dupont (DD) is a leading specialty chemical company in the process of spinning off its electronics business, which in our view should unlock shareholder value. KKR (KKR) is a leading private equity in
Abbott Laboratories $ABT Shares Bought by Americana Partners LLC
04:10am, Tuesday, 11'th Nov 2025
Americana Partners LLC grew its position in Abbott Laboratories (NYSE: ABT) by 40.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fun
2 Top Dividend Stocks to Buy and Hold Forever
07:30am, Monday, 10'th Nov 2025
Dividend stocks can help meet the needs of a variety of investors. The two dividend stocks below are among the leaders in their industries.
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
10:01am, Wednesday, 05'th Nov 2025
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Best Dividend Aristocrats For November 2025
10:25am, Saturday, 01'st Nov 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW
Abbott Showcases World's First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV
01:00pm, Thursday, 30'th Oct 2025
Boston Teacher Shares Life-Changing Experience with Breakthrough Dual Chamber Leadless Pacemaker During Nationwide Interviews in Conjunction with D S Simon Media Boston Teacher Shares Life-Changing Ex
HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment?
10:11am, Thursday, 30'th Oct 2025
Hologic's $18.3B buyout deal and Abbott's strong growth across key segments set up a close contest for MedTech investors.
Goldman Sachs Still Says Sell-Off Coming – 5 Safe Conviction List Picks
12:25pm, Sunday, 26'th Oct 2025
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest United States corporations by total revenue.
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
10:00am, Wednesday, 22'nd Oct 2025
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports
07:34am, Tuesday, 21'st Oct 2025
Walmart will become the first U.S. retailer to sell an over-the-counter continuous glucose monitor in physical stores, as Abbott Laboratories' Lingo rolls out to more than 3,500 locations and online,
Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains
10:35am, Monday, 20'th Oct 2025
Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.
Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming
09:39am, Saturday, 18'th Oct 2025
The market has overreacted to ABT's lowered FY2025 organic sales growth/narrowed adj. EPS, since the management continues to deliver robust numbers while building upon FY2024 outperformance. Much of i
Abbott Laboratories' October Price Plunge Is a Signal to Buy
10:27am, Friday, 17'th Oct 2025
Abbott Laboratories' NYSE: ABT October price plunge is a signal to buy, as analyst and institutional trends suggest they, too, will be buying the stock. Analyst trends revealed by MarketBeat data incl
